In ₹ Crore except Per Share 12 Months Ending | Q4 FY26 31/03/2026 | Q1 FY27 30/06/2026 | |
|---|---|---|---|
| Revenue from Operations | 129.4 | 77.5 | |
| Other Income | 0.0 | 0.6 | |
| Total Income | 129.4 | 78.1 | |
| Expenses | |||
| + Cost of Materials Consumed | 115.5 | 68.0 | |
| + Purchases of Stock-in-Trade | 11.4 | 11.3 | |
| + Changes in Inventories | -18.2 | -15.9 | |
| + Employee Benefit Expense | 2.1 | 2.0 | |
| + Finance Costs | 3.5 | 2.9 | |
| + Depreciation & Amortisation | 1.8 | 1.9 | |
| + Other Expenses | 3.0 | 2.9 | |
| Total Expenses | 119.2 | 73.2 | |
| EBITDA | 15.6 | 9.1 | |
| EBIT | 13.7 | 7.2 | |
| Profit | |||
| PBT before Exceptional Items | 10.2 | 4.8 | |
| Pretax Income | 10.2 | 4.8 | |
| + Current Tax | 3.5 | 1.4 | |
| + Deferred Tax | -0.0 | 0.4 | |
| Tax Expense | 3.5 | 1.7 | |
| Net Income | 6.8 | 3.1 | |
| + Net Income — Continuing Ops | 6.8 | 3.1 | |
| + Other Comprehensive Income | 0.1 | 0.0 | |
| Total Comprehensive Income | 6.8 | 3.1 | |
| Per Share | |||
| Basic EPS | 3.32 | 0.98 | |
| Diluted EPS | 3.22 | 0.98 | |
| Other Comprehensive Income — detail | |||
| + Other Comprehensive Income | 0.1 | 0.0 | |
| + Items NOT to be Reclassified to P&L | 0.1 | 0.0 | |
| + Tax on Items NOT to be Reclassified | 0.0 | 0.0 | |
| Per Share — as-filed variants | |||
| Basic EPS — Continuing Operations | 1.66 | 0.98 | |
| Diluted EPS — Continuing Operations | 1.61 | 0.98 | |
| Basic EPS — Discontinued Operations | 1.66 | 0.00 | |
| Diluted EPS — Discontinued Operations | 1.61 | 0.00 | |
| Regulatory Disclosures — filed alongside, not part of the P&L | |||
| Related-party Transactions — During the Period | 4.3 | — | |
| Derived — Gross Profit (Revenue − Materials − Purchases − Δ Inventories) | |||
| Gross Profit | 20.6 | 14.0 | |
| Gross Margin % | 15.94 | 18.13 | |
| Adjusted (ex-Exceptional Items) — derived | |||
| Pretax Income (Adjusted, as filed) | 10.2 | 4.8 | |
| Net Income Adj (tax-effected) | 6.8 | 3.1 | |
| EPS Adj | 3.32 | 0.98 | |
| Other Filed Concepts — mapped but not yet placed in the schedule | |||
| Face Value | 10.00 | 10.00 | |
| Paid Up Equity Capital | 31.6 | 31.6 | |